Clinical Trials
3 trialsNCT01732549 2019-11-22
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
Ipsen
Phase 2 Terminated
NCT01743469 2019-01-08
A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
Ipsen
Phase 2 Completed
NCT00560482 2015-10-26
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Active Biotech AB
Phase 2 Completed